Drug intelligence / Profile preview

Sporidiobolus pararoseus

Development stage
Unknown
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral, Topical
01

Overview

Sporidiobolus pararoseus is a species of red yeast belonging to the class Basidiomycetes. It is widely used as a feed additive in animal nutrition, particularly in poultry, due to its ability to act as a mycotoxin binder and prebiotic with antioxidant properties[1][7][8]. The yeast produces several bioactive compounds, including carotenoids such as torularhodin (a precursor of vitamin A), β-carotene, γ-carotene, and torulene[2][7]. These compounds contribute to its strong antioxidant activity by scavenging free radicals and activating cellular defense pathways like Nrf2/ARE[2][7]. In addition to reducing oxidative stress and inflammation, S. pararoseus supplementation has been shown to improve production traits in poultry (e.g., egg quality), ameliorate diabetic nephropathy in animal models by lowering glucose levels and improving kidney function markers[7], enhance resistance against postharvest blue mold decay in apples through induction of plant defense enzymes[6], and serve as an environmentally friendly alternative for food safety applications. Its mechanism involves binding mycotoxins in the gut (reducing their absorption), modulating detoxification enzyme expression (such as cytochrome P450s), enhancing antioxidant defenses via Nrf2 pathway activation, and possibly modulating immune responses through anti-inflammatory effects mediated by carotenoids like torularhodin[1][2][5][6].

Other names
red yeastS. pararoseus
02

Targets

Cyp (Cyclophilin family)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on Sporidiobolus pararoseus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sporidiobolus pararoseus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call